List of Tables
Table 1. Global Vaccines For Children Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Vaccines For Children Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Vaccines For Children Market Competitive Situation by Manufacturers in 2024
Table 4. Global Vaccines For Children Sales (K Doses) of Key Manufacturers (2020-2025)
Table 5. Global Vaccines For Children Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Vaccines For Children Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Vaccines For Children Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Vaccines For Children Average Price (US$/Dose) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Vaccines For Children, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Vaccines For Children, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Vaccines For Children, Product Type & Application
Table 12. Global Key Manufacturers of Vaccines For Children, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Vaccines For Children by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaccines For Children as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Vaccines For Children Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Vaccines For Children Sales by Region (2020-2025) & (K Doses)
Table 18. Global Vaccines For Children Sales Market Share by Region (2020-2025)
Table 19. Global Vaccines For Children Sales by Region (2026-2031) & (K Doses)
Table 20. Global Vaccines For Children Sales Market Share by Region (2026-2031)
Table 21. Global Vaccines For Children Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Vaccines For Children Revenue Market Share by Region (2020-2025)
Table 23. Global Vaccines For Children Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Vaccines For Children Revenue Market Share by Region (2026-2031)
Table 25. North America Vaccines For Children Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Vaccines For Children Sales by Country (2020-2025) & (K Doses)
Table 27. North America Vaccines For Children Sales by Country (2026-2031) & (K Doses)
Table 28. North America Vaccines For Children Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Vaccines For Children Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Vaccines For Children Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Vaccines For Children Sales by Country (2020-2025) & (K Doses)
Table 32. Europe Vaccines For Children Sales by Country (2026-2031) & (K Doses)
Table 33. Europe Vaccines For Children Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Vaccines For Children Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Vaccines For Children Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Vaccines For Children Sales by Region (2020-2025) & (K Doses)
Table 37. Asia Pacific Vaccines For Children Sales by Region (2026-2031) & (K Doses)
Table 38. Asia Pacific Vaccines For Children Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Vaccines For Children Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Vaccines For Children Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Vaccines For Children Sales by Country (2020-2025) & (K Doses)
Table 42. Latin America Vaccines For Children Sales by Country (2026-2031) & (K Doses)
Table 43. Latin America Vaccines For Children Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Vaccines For Children Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Vaccines For Children Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Vaccines For Children Sales by Country (2020-2025) & (K Doses)
Table 47. Middle East and Africa Vaccines For Children Sales by Country (2026-2031) & (K Doses)
Table 48. Middle East and Africa Vaccines For Children Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Vaccines For Children Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Vaccines For Children Sales (K Doses) by Type (2020-2025)
Table 51. Global Vaccines For Children Sales (K Doses) by Type (2026-2031)
Table 52. Global Vaccines For Children Sales Market Share by Type (2020-2025)
Table 53. Global Vaccines For Children Sales Market Share by Type (2026-2031)
Table 54. Global Vaccines For Children Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Vaccines For Children Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Vaccines For Children Revenue Market Share by Type (2020-2025)
Table 57. Global Vaccines For Children Revenue Market Share by Type (2026-2031)
Table 58. Global Vaccines For Children Price (US$/Dose) by Type (2020-2025)
Table 59. Global Vaccines For Children Price (US$/Dose) by Type (2026-2031)
Table 60. Global Vaccines For Children Sales (K Doses) by Application (2020-2025)
Table 61. Global Vaccines For Children Sales (K Doses) by Application (2026-2031)
Table 62. Global Vaccines For Children Sales Market Share by Application (2020-2025)
Table 63. Global Vaccines For Children Sales Market Share by Application (2026-2031)
Table 64. Global Vaccines For Children Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Vaccines For Children Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Vaccines For Children Revenue Market Share by Application (2020-2025)
Table 67. Global Vaccines For Children Revenue Market Share by Application (2026-2031)
Table 68. Global Vaccines For Children Price (US$/Dose) by Application (2020-2025)
Table 69. Global Vaccines For Children Price (US$/Dose) by Application (2026-2031)
Table 70. GSK Company Information
Table 71. GSK Description and Business Overview
Table 72. GSK Vaccines For Children Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 73. GSK Vaccines For Children Product
Table 74. GSK Recent Developments/Updates
Table 75. Sanofi Company Information
Table 76. Sanofi Description and Business Overview
Table 77. Sanofi Vaccines For Children Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 78. Sanofi Vaccines For Children Product
Table 79. Sanofi Recent Developments/Updates
Table 80. Merck Company Information
Table 81. Merck Description and Business Overview
Table 82. Merck Vaccines For Children Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 83. Merck Vaccines For Children Product
Table 84. Merck Recent Developments/Updates
Table 85. Pfizer Company Information
Table 86. Pfizer Description and Business Overview
Table 87. Pfizer Vaccines For Children Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 88. Pfizer Vaccines For Children Product
Table 89. Pfizer Recent Developments/Updates
Table 90. Jintan Company Information
Table 91. Jintan Description and Business Overview
Table 92. Jintan Vaccines For Children Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 93. Jintan Vaccines For Children Product
Table 94. Jintan Recent Developments/Updates
Table 95. CSL Company Information
Table 96. CSL Description and Business Overview
Table 97. CSL Vaccines For Children Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 98. CSL Vaccines For Children Product
Table 99. CSL Recent Developments/Updates
Table 100. MedImmune LLC Company Information
Table 101. MedImmune LLC Description and Business Overview
Table 102. MedImmune LLC Vaccines For Children Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 103. MedImmune LLC Vaccines For Children Product
Table 104. MedImmune LLC Recent Developments/Updates
Table 105. J&J(Crucell) Company Information
Table 106. J&J(Crucell) Description and Business Overview
Table 107. J&J(Crucell) Vaccines For Children Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 108. J&J(Crucell) Vaccines For Children Product
Table 109. J&J(Crucell) Recent Developments/Updates
Table 110. China National Biotec Company Information
Table 111. China National Biotec Description and Business Overview
Table 112. China National Biotec Vaccines For Children Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 113. China National Biotec Vaccines For Children Product
Table 114. China National Biotec Recent Developments/Updates
Table 115. Tiantan Company Information
Table 116. Tiantan Description and Business Overview
Table 117. Tiantan Vaccines For Children Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 118. Tiantan Vaccines For Children Product
Table 119. Tiantan Recent Developments/Updates
Table 120. Hualan Company Information
Table 121. Hualan Description and Business Overview
Table 122. Hualan Vaccines For Children Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 123. Hualan Vaccines For Children Product
Table 124. Hualan Recent Developments/Updates
Table 125. Kangtai Company Information
Table 126. Kangtai Description and Business Overview
Table 127. Kangtai Vaccines For Children Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 128. Kangtai Vaccines For Children Product
Table 129. Kangtai Recent Developments/Updates
Table 130. Hissen Company Information
Table 131. Hissen Description and Business Overview
Table 132. Hissen Vaccines For Children Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 133. Hissen Vaccines For Children Product
Table 134. Hissen Recent Developments/Updates
Table 135. Johnson & Johnson Company Information
Table 136. Johnson & Johnson Description and Business Overview
Table 137. Johnson & Johnson Vaccines For Children Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 138. Johnson & Johnson Vaccines For Children Product
Table 139. Johnson & Johnson Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Vaccines For Children Distributors List
Table 143. Vaccines For Children Customers List
Table 144. Vaccines For Children Market Trends
Table 145. Vaccines For Children Market Drivers
Table 146. Vaccines For Children Market Challenges
Table 147. Vaccines For Children Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
Table 151. Authors List of This Report
List of Figures
Figure 1. Product Picture of Vaccines For Children
Figure 2. Global Vaccines For Children Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Vaccines For Children Market Share by Type: 2024 & 2031
Figure 4. Recombinant Vaccines Product Picture
Figure 5. Viral Vaccines Product Picture
Figure 6. Polysaccharide Vaccines Product Picture
Figure 7. Others Product Picture
Figure 8. Global Vaccines For Children Market Value by Application (2020-2031) & (US$ Million)
Figure 9. Global Vaccines For Children Market Share by Application: 2024 & 2031
Figure 10. Hospital
Figure 11. Clinic
Figure 12. Global Vaccines For Children Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Vaccines For Children Market Size (2020-2031) & (US$ Million)
Figure 14. Global Vaccines For Children Sales (2020-2031) & (K Doses)
Figure 15. Global Vaccines For Children Average Price (US$/Dose) & (2020-2031)
Figure 16. Vaccines For Children Report Years Considered
Figure 17. Vaccines For Children Sales Share by Manufacturers in 2024
Figure 18. Global Vaccines For Children Revenue Share by Manufacturers in 2024
Figure 19. Global 5 and 10 Largest Vaccines For Children Players: Market Share by Revenue in Vaccines For Children in 2024
Figure 20. Vaccines For Children Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 21. Global Vaccines For Children Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 22. North America Vaccines For Children Sales Market Share by Country (2020-2031)
Figure 23. North America Vaccines For Children Revenue Market Share by Country (2020-2031)
Figure 24. U.S. Vaccines For Children Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Canada Vaccines For Children Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Europe Vaccines For Children Sales Market Share by Country (2020-2031)
Figure 27. Europe Vaccines For Children Revenue Market Share by Country (2020-2031)
Figure 28. Germany Vaccines For Children Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. France Vaccines For Children Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. U.K. Vaccines For Children Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Italy Vaccines For Children Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Russia Vaccines For Children Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Asia Pacific Vaccines For Children Sales Market Share by Region (2020-2031)
Figure 34. Asia Pacific Vaccines For Children Revenue Market Share by Region (2020-2031)
Figure 35. China Vaccines For Children Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Japan Vaccines For Children Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. South Korea Vaccines For Children Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. India Vaccines For Children Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Australia Vaccines For Children Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Taiwan Vaccines For Children Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Indonesia Vaccines For Children Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Thailand Vaccines For Children Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Malaysia Vaccines For Children Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Philippines Vaccines For Children Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Latin America Vaccines For Children Sales Market Share by Country (2020-2031)
Figure 46. Latin America Vaccines For Children Revenue Market Share by Country (2020-2031)
Figure 47. Mexico Vaccines For Children Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Brazil Vaccines For Children Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Argentina Vaccines For Children Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Middle East and Africa Vaccines For Children Sales Market Share by Country (2020-2031)
Figure 51. Middle East and Africa Vaccines For Children Revenue Market Share by Country (2020-2031)
Figure 52. Turkey Vaccines For Children Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Saudi Arabia Vaccines For Children Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. U.A.E Vaccines For Children Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Global Sales Market Share of Vaccines For Children by Type (2020-2031)
Figure 56. Global Revenue Market Share of Vaccines For Children by Type (2020-2031)
Figure 57. Global Vaccines For Children Price (US$/Dose) by Type (2020-2031)
Figure 58. Global Sales Market Share of Vaccines For Children by Application (2020-2031)
Figure 59. Global Revenue Market Share of Vaccines For Children by Application (2020-2031)
Figure 60. Global Vaccines For Children Price (US$/Dose) by Application (2020-2031)
Figure 61. Vaccines For Children Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
